A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma

Author： Hamid Omid   Ilaria Robert   Garbe Claus   Wolter Pascal   Maio Michele   Hutson Thomas E.   Arance Ana   Lorigan Paul   Lee Jeeyun   Hauschild Axel   Mohr Peter   Hahka-Kemppinen Marjo   Kaiser Christopher   Turner P. Kellie   Conti Ilaria   Grob Jean-Jacques  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|13|2016-2024

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.13, 2014-07, pp. : 2016-2024

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder: A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial

By Han Changsu   Pae Chi-Un   Lee Bun-Hee   Ko Young-Hoon   Masand Prakash S.   Patkar Ashwin A.   Joe Sook-Haeng   Jung In-Kwa  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Comparison between High and Low Molecular Weight Hyaluronates in Knee Osteoarthritis Patients: Open-label, Randomized, Multicentre Clinical Trial

By Lee PB   Kim YC   Lim YJ   Lee CJ   Sim WS   Ha CW   Bin SI   Lim KB   Choi SS   Lee SC  

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 77-87

Field House Publishing

Access to resources Recommend Favorite

Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial

By Rizkallah Élie   Stip Emmanuel   Zhornitsky Simon   Pampoulova Tania   Gendron Alain   Rompré Pierre-Paul   Chiasson Jean-Pierre   Potvin Stéphane  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2947-2951

Informa Healthcare

Access to resources Recommend Favorite

A randomized phase 2 trial of erlotinib versus pemetrexed as second-line therapy in the treatment of patients with advanced EGFR wild-type and EGFR FISH-positive lung adenocarcinoma

By Li Ning   Ou Wei   Yang Hua   Liu Qian-Wen   Zhang Song-Liang   Wang Bao-Xiao   Wang Si-Yu  

Cancer, Vol. 120, Iss. 9, 2014-05 ,pp. : 1379-1386

Blackwell Publishing

Access to resources Recommend Favorite

Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer

By Doebele Robert C.   Spigel David   Tehfe Mustapha   Thomas Sachdev   Reck Martin   Verma Sunil   Eakle Janice   Bustin Frederique   Goldschmidt Jerome   Cao Dachuang   Alexandris Ekaterine   Yurasov Sergey   Camidge D. Ross   Bonomi Philip  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 883-892

Blackwell Publishing

Access to resources Recommend Favorite